Author

Arnault Tauziède‐Espariat

Observed names: A Tauziede-Espariat, A Tauziède-Espariat, A. Tauziede, A. Tauziede-Espariat, A. Tauziede‐Espariat, A. Tauziède-Espariat, A. Tauziède‐Espariat, Arnault TAUZIEDE-ESPARIAT, Arnault Tauziede Espariat, Arnault Tauziede-Espariat, Arnault Tauziede-espariat, Arnault Tauziede‐Espariat, Arnault Tauziède-Espariat, Arnault Tauziède-Espariat, Tauziede, Arnault, Tauziede-Espariat, A., Tauziede-Espariat, Arnault, Tauziède-Espariat, Arnault, Tauziède-Espariat, A., Tauziède-Espariat, Arnault, tauziede, Arnault

Institutions: Lyon 1 Université, Inserm, Université Paris Cité, Hospices Civils de Lyon, Centre Hospitalier Sainte-Anne, Institut de Psychiatrie et Neurosciences de Paris, Institut du Cerveau, GHU Paris psychiatrie & neurosciences, Centre pour l'innovation en cancérologie de Lyon

Observed institutions: Lyon 1 Université, Université Paris-Sud, Hôpital Necker-Enfants Malades, Inserm, Université Paris Cité, Centre hospitalier national d'ophtalmologie des Quinze-Vingts, Institut Gustave Roussy, Amsterdam UMC Location University of Amsterdam, Université de technologie de belfort-montbéliard, Institut Necker Enfants Malades, Centre Hospitalier Universitaire de Besançon, Hôpital Charles-Nicolle, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hospices Civils de Lyon, Hôpital Lariboisière, Pitié-Salpêtrière Hospital, Centre Hospitalier Sainte-Anne, Institut de Psychiatrie et Neurosciences de Paris, L'Hôpital Nord Franche-Comté, Ste. Anne's Hospital, Institut de Recherche en Cancérologie de Montpellier, Centre for Psychiatry and Neuroscience, Amsterdam University Medical Centers, Institut du Cerveau, GHU Paris psychiatrie & neurosciences, Université Paris Diderot, Institut Regional du Cancer de Montpellier, NeuroDiderot, Université Paris Descartes, Centre pour l'innovation en cancérologie de Lyon, Institut für Neuropathologie, Fondation Gustave Roussy, Institut Curie, University of Amsterdam, Université de Franche-Comté

ORCID: 0000-0002-9979-0297

Observed ORCIDs: 0000-0002-9979-0297, 0000-0002-9795-5828

OpenAlex ID: A5044869256

Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation

2020 · David Castel, Thomas Kergrohen, et al. · Acta Neuropathologica · 186

Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors

2019 · Amaury Leruste, Jimena Tosello, et al. · Cancer Cell · 161

Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features

2018 · Felipe Andreiuolo, Pascale Varlet, et al. · Brain Pathology · 142

Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course

2019 · Annika K. Wefers, Damian Stichel, et al. · Acta Neuropathologica · 135

Co‐occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma

2016 · Mélanie Pagès, Kevin Beccaria, et al. · Brain Pathology · 132

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging

2018 · Mélanie Pagès, Kristian W. Pajtler, et al. · Brain Pathology · 106

High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts

2020 · Alexandre Roux, Johan Pallud, et al. · Neuro-Oncology · 91

Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors

2016 · Arnault Tauziède-Espariat, Damien Bresson, et al. · Journal of Neuropathology & Experimental Neurology · 84

Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis

2017 · Arnault Tauziede‐Espariat, Béatrice Parfait, et al. · Brain Pathology · 79

La classification de l’OMS 2021 des tumeurs du système nerveux central

2021 · Dominique Figarella-Branger, Romain Appay, et al. · Annales de Pathologie · 75

Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions

2021 · Arnault Tauziède-Espariat, Aurore Siegfried, et al. · Acta Neuropathologica Communications · 68

A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation

2023 · Lucie Auffret, Yassine Ajlil, et al. · Acta Neuropathologica · 66

Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma

2016 · Marc Zanello, Mélanie Pages, et al. · Journal of Neuropathology & Experimental Neurology · 66

Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion

2015 · Melanie Pages, Ludovic Lacroix, et al. · Acta Neuropathologica Communications · 64

ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1-related tumors

2018 · Emmanuelle Uro-Coste, Julien Masliah-Planchon, et al. · Acta Neuropathologica · 63

Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

2020 · Philipp Sievers, Martin Sill, et al. · Acta Neuropathologica · 60

K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway

2016 · N. Joyon, A. Tauziède‐Espariat, et al. · Neuropathology and Applied Neurobiology · 59

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression

2020 · C. Antin, A. Tauziède-Espariat, et al. · Acta Neuropathologica Communications · 52

The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts

2020 · A. Tauziède-Espariat, M-A Debily, et al. · Acta Neuropathologica Communications · 47

Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading

2019 · on behalf of the RENOCLIP-LOC, Arnault Tauziède-Espariat, et al. · Acta Neuropathologica Communications · 47

ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review

2018 · Albane Gareton, Gaëlle Pierron, et al. · Journal of Neuropathology & Experimental Neurology · 47

High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors

2017 · Céline Chauvin, Amaury Leruste, et al. · Cell Reports · 45

NTRK‐rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class

2022 · Arnault Tauziède‐Espariat, Mathilde Duchesne, et al. · Histopathology · 40

The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population

2019 · Albane Gareton, Arnault Tauziède-Espariat, et al. · Acta Neuropathologica · 39

An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)

2019 · A. Tauziède-Espariat, M-A Debily, et al. · Acta Neuropathologica Communications · 38

Works count: 420

Citation count: 3,570

H-index: 30

I10-index: 84